MANHATTAN ASSOCIATES INC (MANH) Fundamental Analysis & Valuation

NASDAQ:MANH • US5627501092

Current stock price

140.13 USD
+2.24 (+1.62%)
At close:
140.13 USD
0 (0%)
After Hours:

This MANH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. MANH Profitability Analysis

1.1 Basic Checks

  • MANH had positive earnings in the past year.
  • In the past year MANH had a positive cash flow from operations.
  • Each year in the past 5 years MANH has been profitable.
  • MANH had a positive operating cash flow in each of the past 5 years.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • MANH has a better Return On Assets (29.26%) than 98.16% of its industry peers.
  • MANH has a Return On Equity of 105.60%. This is amongst the best in the industry. MANH outperforms 98.16% of its industry peers.
  • MANH's Return On Invested Capital of 82.91% is amongst the best of the industry. MANH outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MANH is significantly above the industry average of 11.04%.
  • The 3 year average ROIC (56.95%) for MANH is below the current ROIC(82.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 29.26%
ROE 105.6%
ROIC 82.91%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • MANH has a Profit Margin of 19.68%. This is amongst the best in the industry. MANH outperforms 86.40% of its industry peers.
  • MANH's Profit Margin has improved in the last couple of years.
  • MANH has a better Operating Margin (25.91%) than 91.18% of its industry peers.
  • In the last couple of years the Operating Margin of MANH has grown nicely.
  • MANH has a worse Gross Margin (56.00%) than 63.97% of its industry peers.
  • MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.91%
PM (TTM) 19.68%
GM 56%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. MANH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MANH is creating value.
  • MANH has less shares outstanding than it did 1 year ago.
  • MANH has less shares outstanding than it did 5 years ago.
  • MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • MANH has an Altman-Z score of 12.59. This indicates that MANH is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of MANH (12.59) is better than 91.18% of its industry peers.
  • MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.59
ROIC/WACC7.6
WACC10.91%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • MANH has a Current Ratio of 1.10. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MANH (1.10) is worse than 70.96% of its industry peers.
  • MANH has a Quick Ratio of 1.10. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.10, MANH is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
  • MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MANH Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.70% over the past year.
  • The Earnings Per Share has been growing by 23.57% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 4.78% in the past year.
  • MANH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.02% yearly.
EPS 1Y (TTM)4.7%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%4.2%
Revenue 1Y (TTM)4.78%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%7.39%

3.2 Future

  • MANH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.27% yearly.
  • Based on estimates for the next years, MANH will show a quite strong growth in Revenue. The Revenue will grow by 8.60% on average per year.
EPS Next Y4.93%
EPS Next 2Y8.79%
EPS Next 3Y9.72%
EPS Next 5Y18.27%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.02%
Revenue Next 5Y8.6%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. MANH Valuation Analysis

4.1 Price/Earnings Ratio

  • MANH is valuated quite expensively with a Price/Earnings ratio of 27.37.
  • The rest of the industry has a similar Price/Earnings ratio as MANH.
  • The average S&P500 Price/Earnings ratio is at 26.64. MANH is around the same levels.
  • A Price/Forward Earnings ratio of 23.35 indicates a rather expensive valuation of MANH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MANH indicates a somewhat cheap valuation: MANH is cheaper than 60.29% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, MANH is valued at the same level.
Industry RankSector Rank
PE 27.37
Fwd PE 23.35
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 66.91% of the companies in the same industry are more expensive than MANH, based on the Enterprise Value to EBITDA ratio.
  • 70.96% of the companies in the same industry are more expensive than MANH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.87
EV/EBITDA 27.67
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MANH does not grow enough to justify the current Price/Earnings ratio.
  • MANH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.55
PEG (5Y)1.16
EPS Next 2Y8.79%
EPS Next 3Y9.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MANH Dividend Analysis

5.1 Amount

  • MANH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MANH Fundamentals: All Metrics, Ratios and Statistics

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (5/1/2026, 8:00:01 PM)

After market: 140.13 0 (0%)

140.13

+2.24 (+1.62%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry Strength8.7
Industry Growth62.73
Earnings (Last)04-21
Earnings (Next)07-20
Inst Owners105.68%
Inst Owner Change0.38%
Ins Owners1.21%
Ins Owner Change0.24%
Market Cap8.30B
Revenue(TTM)1.10B
Net Income(TTM)216.66M
Analysts83.16
Price Target196.51 (40.23%)
Short Float %4.45%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.39%
Min EPS beat(2)5.72%
Max EPS beat(2)9.06%
EPS beat(4)4
Avg EPS beat(4)10.52%
Min EPS beat(4)5.72%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)13.66%
EPS beat(12)12
Avg EPS beat(12)17.14%
EPS beat(16)16
Avg EPS beat(16)20.47%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-0.17%
Max Revenue beat(2)1.04%
Revenue beat(4)2
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)0.27%
Revenue beat(12)8
Avg Revenue beat(12)1.4%
Revenue beat(16)12
Avg Revenue beat(16)2.52%
PT rev (1m)-9.48%
PT rev (3m)-12.05%
EPS NQ rev (1m)0.31%
EPS NQ rev (3m)-3%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-1.62%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 27.37
Fwd PE 23.35
P/S 7.54
P/FCF 21.87
P/OCF 20.84
P/B 40.46
P/tB 58.08
EV/EBITDA 27.67
EPS(TTM)5.12
EY3.65%
EPS(NY)6
Fwd EY4.28%
FCF(TTM)6.41
FCFY4.57%
OCF(TTM)6.72
OCFY4.8%
SpS18.58
BVpS3.46
TBVpS2.41
PEG (NY)5.55
PEG (5Y)1.16
Graham Number19.9747 (-85.75%)
Profitability
Industry RankSector Rank
ROA 29.26%
ROE 105.6%
ROCE 104.44%
ROIC 82.91%
ROICexc 481.8%
ROICexgc N/A
OM 25.91%
PM (TTM) 19.68%
GM 56%
FCFM 34.48%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
ROICexc(3y)364.11%
ROICexc(5y)380.76%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)71.74%
ROCE(5y)64.28%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-0.52%
ROICexc growth 5Y23.6%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
F-Score7
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 282.48%
Cap/Sales 1.7%
Interest Coverage 250
Cash Conversion 136.44%
Profit Quality 175.2%
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 12.59
F-Score7
WACC10.91%
ROIC/WACC7.6
Cap/Depr(3y)154.87%
Cap/Depr(5y)122.75%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.85%
Profit Quality(3y)145.98%
Profit Quality(5y)147.21%
High Growth Momentum
Growth
EPS 1Y (TTM)4.7%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%4.2%
EPS Next Y4.93%
EPS Next 2Y8.79%
EPS Next 3Y9.72%
EPS Next 5Y18.27%
Revenue 1Y (TTM)4.78%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%7.39%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.02%
Revenue Next 5Y8.6%
EBIT growth 1Y7.1%
EBIT growth 3Y22.8%
EBIT growth 5Y19.9%
EBIT Next Year8.14%
EBIT Next 3Y9.69%
EBIT Next 5Y13.03%
FCF growth 1Y60.91%
FCF growth 3Y29.3%
FCF growth 5Y22.03%
OCF growth 1Y64.39%
OCF growth 3Y29.44%
OCF growth 5Y22.55%

MANHATTAN ASSOCIATES INC / MANH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status for MANH stock?

ChartMill assigns a valuation rating of 4 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Fairly Valued.


Can you provide the profitability details for MANHATTAN ASSOCIATES INC?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


What are the PE and PB ratios of MANHATTAN ASSOCIATES INC (MANH) stock?

The Price/Earnings (PE) ratio for MANHATTAN ASSOCIATES INC (MANH) is 27.37 and the Price/Book (PB) ratio is 40.46.


What is the earnings growth outlook for MANHATTAN ASSOCIATES INC?

The Earnings per Share (EPS) of MANHATTAN ASSOCIATES INC (MANH) is expected to grow by 4.93% in the next year.